Published: 11 April 2002
Analyst(s): Kathia Desronvil, Roddy Martin
Increased FDA pressures are forcing regulated life sciences companies to take a proactive and automated approach to their corrective action management strategies. Companies are now required to have a comprehensive integrated quality management strategy in place that encompasses the maze of quality management islands across all areas of manufacturing operations. Traditionally, companies have been reactive in developing a systematic process/plan to address nonconformance to FDA regulations, which has largely been based on the validation of cGMP systems. 30% to 50% of all 483 citations are related to CAPA.
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see
Guiding Principles on Independence and Objectivity.